@prefix orcid: .
@prefix this: .
@prefix sub: .
@prefix np: .
@prefix rdf: .
@prefix xsd: .
@prefix rdfs: .
@prefix ns2: .
@prefix ns1: .
@prefix prov: .
@prefix ns3: .
@prefix npx: .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubInfo .
}
sub:assertion {
ns1:inhibit .
}
sub:provenance {
sub:assertion prov:generatedAtTime "2021-12-16T19:54:25.224230"^^xsd:dateTime;
prov:wasGeneratedBy "S&T TWOC project version 2" .
sub:version prov:value "2"^^xsd:integer .
rdf:OBJECT rdfs:label "both tumor necrosis factor" .
rdf:OBJECT-POSITION rdfs:label "65"^^xsd:integer .
rdf:PREDICATE rdfs:label "inhibited" .
rdf:PREDICATE-POSITION rdfs:label "[50]" .
rdf:SUBJECT rdfs:label "dexamethasone ( DEX )" .
rdf:SUBJECT-POSITION rdfs:label "15"^^xsd:integer .
rdfs:ABSTRACT-UID ns2:50 "ewg8q1io" .
rdfs:SENTENCE rdfs:label "glycyrrhizin (GL), as well as dexamethasone (DEX) inhibited both tumor necrosis factor (TNF)-α –and IL-1β –induced IL-8 production, mRNA expression, and promoter activity in A549 lung epithelial cells." .
rdfs:TRIPLE-UID ns3:ewg8q1io-TRIPLE-ABSTRACT-1 "ewg8q1io-TRIPLE-ABSTRACT-1" .
rdfs:label "dex" .
rdfs:label "tumor necrosis factor" .
}
sub:pubInfo {
sub:assertion prov:wasDerivedFrom .
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
npx:hasSignature "Kc4Gu2aAhgBNJpDv+GNJDd8iKJ6lhwoOlVMlHI12QFRl3NnE93dlEPvEBKLeCRAO3ZhOFui6RQoNyb7tubKmtZZkzxt1eAGkglESSmR8W7fVMYf1aSCD+GTerNSXsu1yUgPi56RbSMRWSvexyhtlz4vZZLjTb1Sx5mmjnU6iYE8=";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2021-12-16T19:54:25.224230"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}